Klingenstein Fields & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.1M Sell
293,939
-994
-0.3% -$88.6K 0.99% 33
2025
Q4
$23.3M Sell
294,933
-6,236
-2% -$489K 0.87% 34
2025
Q3
$24.1M Sell
301,169
-1,887
-0.6% -$161K 0.91% 36
2025
Q2
$27.5M Sell
303,056
-3,905
-1% -$356K 1.09% 34
2025
Q1
$28.8M Sell
306,961
-6,555
-2% -$587K 1.22% 28
2024
Q4
$28.5M Sell
313,516
-6,050
-2% -$577K 1.15% 29
2024
Q3
$33.2M Sell
319,566
-1,216
-0.4% -$124K 1.32% 26
2024
Q2
$31.1M Sell
320,782
-3,873
-1% -$357K 1.29% 27
2024
Q1
$29.2M Sell
324,655
-32,110
-9% -$2.72M 1.21% 29
2023
Q4
$28.4M Sell
356,765
-686
-0.2% -$51.6K 1.27% 26
2023
Q3
$25.4M Sell
357,451
-4,948
-1% -$370K 1.24% 27
2023
Q2
$27.9M Sell
362,399
-5,871
-2% -$454K 1.29% 30
2023
Q1
$27.7M Sell
368,270
-2,111
-0.6% -$157K 1.39% 27
2022
Q4
$29.2M Sell
370,381
-6,133
-2% -$460K 1.51% 24
2022
Q3
$26.4M Sell
376,514
-3,250
-0.9% -$255K 1.45% 28
2022
Q2
$30.4M Sell
379,764
-14,110
-4% -$1.1M 1.58% 19
2022
Q1
$29.9M Sell
393,874
-5,582
-1% -$442K 1.28% 29
2021
Q4
$34.1M Sell
399,456
-1,485
-0.4% -$116K 1.37% 24
2021
Q3
$30.3M Sell
400,941
-6,811
-2% -$541K 1.29% 27
2021
Q2
$33.2M Sell
407,752
-7,856
-2% -$642K 1.37% 26
2021
Q1
$32.8M Sell
415,608
-11,506
-3% -$902K 1.48% 22
2020
Q4
$36.5M Sell
427,114
-2,602
-0.6% -$215K 1.66% 17
2020
Q3
$33.2M Sell
429,716
-6,494
-1% -$495K 1.66% 17
2020
Q2
$32M Sell
436,210
-3,280
-0.7% -$233K 1.75% 15
2020
Q1
$29.2M Sell
439,490
-20,808
-5% -$1.47M 1.9% 12
2019
Q4
$31.7M Sell
460,298
-7,501
-2% -$511K 1.59% 15
2019
Q3
$34.4M Sell
467,799
-14,641
-3% -$1.06M 1.82% 11
2019
Q2
$34.6M Sell
482,440
-17,315
-3% -$1.23M 1.79% 11
2019
Q1
$34.3M Buy
499,755
+46,290
+10% +$2.99M 1.84% 12
2018
Q4
$27M Sell
453,465
-19,473
-4% -$1.22M 1.15% 26
2018
Q3
$31.7M Sell
472,938
-3,538
-0.7% -$236K 1.13% 30
2018
Q2
$30.9M Sell
476,476
-7,678
-2% -$502K 1.18% 26
2018
Q1
$34.7M Sell
484,154
-16,989
-3% -$1.22M 1.33% 19
2017
Q4
$37.8M Sell
501,143
-2,528
-0.5% -$185K 1.39% 18
2017
Q3
$36.7M Buy
503,671
+3,778
+0.8% +$272K 1.41% 16
2017
Q2
$37.1M Sell
499,893
-3,309
-0.7% -$246K 1.45% 16
2017
Q1
$36.8M Sell
503,202
-2,882
-0.6% -$202K 1.5% 15
2016
Q4
$33.1M Sell
506,084
-1,746
-0.3% -$120K 1.45% 18
2016
Q3
$37.6M Sell
507,830
-2,928
-0.6% -$216K 1.73% 11
2016
Q2
$37.4M Buy
510,758
+14,045
+3% +$1M 1.75% 12
2016
Q1
$35.1M Sell
496,713
-20,000
-4% -$1.33M 1.76% 11
2015
Q4
$34.4M Sell
516,713
-11,705
-2% -$779K 1.71% 12
2015
Q3
$33.5M Sell
528,418
-11,700
-2% -$764K 1.66% 13
2015
Q2
$35.3M Sell
540,118
-7,928
-1% -$538K 1.58% 15
2015
Q1
$38M Sell
548,046
-3,207
-0.6% -$222K 1.68% 14
2014
Q4
$38.1M Buy
551,253
+2,021
+0.4% +$136K 1.7% 13
2014
Q3
$35.8M Sell
549,232
-11,088
-2% -$731K 1.56% 15
2014
Q2
$38.2M Sell
560,320
-4,762
-0.8% -$319K 1.62% 14
2014
Q1
$36.7M Sell
565,082
-200,038
-26% -$12.6M 1.64% 15
2013
Q4
$49.9M Sell
765,120
-7,465
-1% -$478K 1.79% 13
2013
Q3
$45.8M Sell
772,585
-210,586
-21% -$12.5M 1.79% 14
2013
Q2
$56.3M Buy
+983,171
New +$58.4M 2.02% 10

Other funds holding CL

Klingenstein Fields & Co's CL Position: Q1 2026 in Review

Klingenstein Fields & Co reduced its Colgate-Palmolive (CL) stake by 0.34% in Q1 2026, selling an estimated $88.6K and leaving 293,939 shares worth $25.1M. The position accounts for 0.99% of the portfolio, ranked #33.

Klingenstein Fields & Co first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $56.3M in Q2 2013. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Klingenstein Fields & Co held 293,939 shares of Colgate-Palmolive worth $25.1M as of Q1 2026.
  • Klingenstein Fields & Co sold 994 Colgate-Palmolive shares in Q1 2026, an estimated $88.6K.
  • Colgate-Palmolive made up 0.99% of Klingenstein Fields & Co's portfolio in Q1 2026, its #33 holding.
  • Klingenstein Fields & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Klingenstein Fields & Co's Colgate-Palmolive position peaked at $56.3M in Q2 2013.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.